Clinical Trial Update: Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of BEAM chemotherapy regimen followed by autologous stem cell transplantation for lymphoma is completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• BEAM Regimen
• CYTARABINE (CYTARABINE)
• Carmustine (carmustine)
• Etoposide (Etoposide)
• Melphalan HCl for Injection (Propylene Glycol-free) (melphalan hydrochloride)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Hodgkin Disease, Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2016-11-11